Ceramides as modulators of cellular and whole-body metabolism
- PMID: 22045572
- PMCID: PMC3204836
- DOI: 10.1172/JCI57144
Ceramides as modulators of cellular and whole-body metabolism
Abstract
Nearly all stress stimuli (e.g., inflammatory cytokines, glucocorticoids, chemotherapeutics, etc.) induce sphingolipid synthesis, leading to the accumulation of ceramides and ceramide metabolites. While the role of these lipids in the regulation of cell growth and death has been studied extensively, recent studies suggest that a primary consequence of ceramide accumulation is an alteration in metabolism. In both cell-autonomous systems and complex organisms, ceramides modify intracellular signaling pathways to slow anabolism, ensuring that catabolism ensues. These ceramide actions have important implications for diseases associated with obesity, such as diabetes and cardiovascular disease.
Figures
Similar articles
-
Ceramides and mitochondrial fatty acid oxidation in obesity.FASEB J. 2017 Apr;31(4):1263-1272. doi: 10.1096/fj.201601156R. Epub 2016 Dec 21. FASEB J. 2017. PMID: 28003342 Review.
-
Ceramide Metabolism Balance, a Multifaceted Factor in Critical Steps of Breast Cancer Development.Int J Mol Sci. 2018 Aug 26;19(9):2527. doi: 10.3390/ijms19092527. Int J Mol Sci. 2018. PMID: 30149660 Free PMC article. Review.
-
A Role for Ceramides, but Not Sphingomyelins, as Antagonists of Insulin Signaling and Mitochondrial Metabolism in C2C12 Myotubes.J Biol Chem. 2016 Nov 11;291(46):23978-23988. doi: 10.1074/jbc.M116.737684. Epub 2016 Oct 4. J Biol Chem. 2016. PMID: 27703011 Free PMC article.
-
Unwrapping the mechanisms of ceramide and fatty acid-initiated signals leading to immune-inflammatory responses in obesity.Int J Biochem Cell Biol. 2021 Jun;135:105972. doi: 10.1016/j.biocel.2021.105972. Epub 2021 Apr 14. Int J Biochem Cell Biol. 2021. PMID: 33864951 Review.
-
Sphingolipids in mitochondria.Biochim Biophys Acta Mol Cell Biol Lipids. 2017 Jan;1862(1):56-68. doi: 10.1016/j.bbalip.2016.09.019. Epub 2016 Sep 30. Biochim Biophys Acta Mol Cell Biol Lipids. 2017. PMID: 27697478 Free PMC article. Review.
Cited by
-
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.J Pharm Pharm Sci. 2024 Apr 19;27:12568. doi: 10.3389/jpps.2024.12568. eCollection 2024. J Pharm Pharm Sci. 2024. PMID: 38706718 Free PMC article. Review.
-
Adiponectin overexpression improves metabolic abnormalities caused by acid ceramidase deficiency but does not prolong lifespan in a mouse model of Farber Disease.Mol Genet Metab Rep. 2024 Apr 3;39:101077. doi: 10.1016/j.ymgmr.2024.101077. eCollection 2024 Jun. Mol Genet Metab Rep. 2024. PMID: 38595987 Free PMC article.
-
Neutral Sphingomyelinase 2 Inhibition Limits Hepatic Steatosis and Inflammation.Cells. 2024 Mar 6;13(5):463. doi: 10.3390/cells13050463. Cells. 2024. PMID: 38474427 Free PMC article.
-
Lipid profile of circulating placental extracellular vesicles during pregnancy identifies foetal growth restriction risk.J Extracell Vesicles. 2024 Feb;13(2):e12413. doi: 10.1002/jev2.12413. J Extracell Vesicles. 2024. PMID: 38353485 Free PMC article.
-
Circulating Lipoprotein Sphingolipids in Chronic Kidney Disease with and without Diabetes.Biomedicines. 2024 Jan 15;12(1):190. doi: 10.3390/biomedicines12010190. Biomedicines. 2024. PMID: 38255295 Free PMC article.
References
-
- Polya JB, Parsons RS. Free ceramide in blood and its relevance to atherosclerosis. I. Med J Aust. 1973;1(18):873–879. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources